Hua Medicine (Shanghai) Ltd. (OTCMKTS:HUMDF – Get Free Report) saw a significant drop in short interest in June. As of June 30th, there was short interest totaling 13,945 shares, a drop of 40.1% from the June 15th total of 23,273 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ? days.
Hua Medicine (Shanghai) Price Performance
Shares of OTCMKTS:HUMDF remained flat at C$0.34 during trading on Friday. Hua Medicine has a fifty-two week low of C$0.34 and a fifty-two week high of C$0.50. The company’s 50-day moving average is C$0.38 and its 200 day moving average is C$0.41.
About Hua Medicine (Shanghai)
Hua Medicine (Shanghai) is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of innovative treatments for Type 2 diabetes and related metabolic disorders. The company’s pipeline comprises both oral and injectable candidates that leverage novel biological targets and proprietary chemistry to improve glycemic control, minimize side effects and enhance patient adherence.
Founded and headquartered in Shanghai, Hua Medicine has established research hubs and strategic partnerships across Asia and Europe.
Read More
- Five stocks we like better than Hua Medicine (Shanghai)
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for Hua Medicine (Shanghai) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hua Medicine (Shanghai) and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg){kind=logo}
